Browse studies

Find your next paid study

27,300 recruiting studies available now

Natural History Study of Parathyroid Disorders

Background: Parathyroid disorders are very common in the general population and include disorders of parathyroid excess, deficiency, or defects in parathyroid…

Parathyroid CancerPrimary HyperparathyroidismPseudohypoparathyroidism+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT04969926

Nemaline Myopathy Clinical Research Network (NM-CTRN)

The goal of this study is to establish a research network to help define the natural disease history and clinical outcome measures for Nemaline Myopathy (NM).

Nemaline Myopathy

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT06774703

Observational

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

The goal of this randomized controlled trial is to evaluate the potential of a customized digital cognitive training intervention to target aspects of brain fu…

Major Depressive DisorderApathy

Estimated

~$10 – $1,125

Actual pay is set by the research site.

AdventHealthNCT05877885

Observational

Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study

This is a single-arm, open label, clinical outcome study to research the durability (success) of receiving a pulsed field ablation (PFA) per standard of care f…

Atrial Fibrillation (AF)

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Northwell HealthNCT07620262

Diamond Blackfan Anemia Registry (DBAR)

The purpose of this study is to maintain a comprehensive registry of patients with the rare inherited bone marrow failure syndrome Diamond Blackfan anemia (DBA…

AnemiaBlood Disease

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Northwell HealthNCT00106015

Assessing Concentrations of Methadone and Its Metabolites

An observational proof of concept method comparison study. Comparing Liquid Chromatography -Mass Spectroscopy to a new Quantitative Lateral Flow Immunoassay wi…

Opioid Use DisorderPain

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Cari Health Inc.NCT06835582

Long-Term Quality Of Life And Symptom Assessment Among Recurrence-Free Patients Who Underwent Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

To evaluate long-term quality of life (QoL) and participant reported symptom burden in disease-free survivors who have undergone cytoreductive surgery with hyp…

Long TermQuality of LifeRecurrence Free+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07871760

Phase 1

A Phase I Trial of Perioperative FLOT(D) With Neoadjuvant Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Resectable Esophageal and Gastro-esophageal Junction Cancer

The goal of this clinical trial is to learn the safety of the addition of PULSAR radiation to standard of care chemotherapy and immunotherapy in people with es…

Gastro-esophageal Junction (GEJ) CancerEsophagus Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT07700420

Phase 2

A Phase II, Single-arm, Multi-center, Open-label Study of Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as an Induction Immunotherapy for Stage II/III TNBC Patients

This is a Phase II trial to assess efficacy and feasibility of pembrolizumab + INBRX-106 as an induction therapy preceding neoadjuvant therapy.

Triple Negative Breast Cancer

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Providence Health & ServicesNCT06353997

Intraoperative Optical Coherence Tomography - Normals

Optical Coherence Tomography (OCT) image data will be evaluated for image quality and used to test post-processing algorithms to improve detection sensitivity …

Healthy Volunteers

Estimated

~$10 – $750

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT04790890

Phase 2

A Phase 2A/B, Multi-center, Open-Label Study Evaluating the Efficacy and Safety of Dabogratinib (TYRA-300) in Participants With Low Grade Upper Tract Urothelial Carcinoma (SURF303)

A Phase 2A/B study of Dabogratinib (TYRA-300) in Low Grade Upper Tract Urothelial Carcinoma

Low Grade Upper Tract Urothelial Carcinoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Tyra Biosciences, IncNCT07265947

Phase 1

A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome

The goal of this clinical trial is to learn if an antisense oligonucleotide (TS1-ASO) can safely treat and potentially prevent neuropsychiatric and neurodevelo…

CACNA1C

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Stanford UniversityNCT07600658